Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals

Neuropharmacology

Volumn 47, Issue 1, 2004, Pages 65-71

  Risso, Francesca ^a   Grilli, Massimo ^a   Parodi, Monica ^a   Bado, Marcella ^a   Raiteri, Maurizio ^a   Marchi, Mario ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Nicotine; NMDA receptors; Noradrenaline release; PKA; Rat hippocampus

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; CEVADINE; IONOMYCIN; MECAMYLAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SYNAPTOSOME;

ANIMALS; CALCIUM; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; MECAMYLAMINE; N-METHYLASPARTATE; NERVE ENDINGS; NICOTINE; PIPECOLIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTOSOMES;

EID: 2542481752     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.02.018     Document Type: Article

References (31)

1. Agnati L.F., Ferre S., Lluis C., Franco R., Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacological Reviews. 55:2003;509-550
2. Alkondon M., Pereira E.F.R., Albuquerque E.X. α-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Research. 810:1998;257-263
3. Aston-Jones G. Norepinephrine. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology: The Fifth Generation of Progress. American College of Neuropsychopharmacology. 2002;47-58 Lippincott Williams and Wilkins, PA, USA
4. Bannermann D.M., Good M.A., Butcher S.P., Ramsay M., Morris R.G.M. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature. 378:1995;182-186
5. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39
6. Cahill L., Prins B., Weber M., McGaugh J.L. Beta-adrenergic activation and memory for emotional events. Nature. 371:1994;702-704
7. Chéramy A., Godeheu G., L'Hirondel M., Glowinski J. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum. Journal of Pharmacology and Experimental Therapeutics. 276:1996;616-625
8. 3H]-dopamine release. British Journal of Pharmacology. 117:1996;595-606
9. Desce J.M., Godeheu G., Galli T., Artaud F., Chéramy A., Glowinski J. L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience. 47:1992;333-339
10. Fassio A., Sala R., Bonanno G., Marchi M., Raiteri M. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. Neuroscience. 90:1999;893-902
11. 2+ ions on N-methyl-D-aspartate (NMDA)-induced noradrenaline release in vitro. Naunyn Schmiedeberg's Archives of Pharmacology. 342:1990;53-60
12. Fink K., Schultheiss R., Göthert M. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. British Journal of Pharmacology. 106:1992;67-72
13. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716
14. Kulak J.M., McIntosh J.M., Yoshikami D., Olivera B.M. Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. Journal of Neurochemistry. 77:2001;1581-1589
15. Lawrence A.D., Sahakian B.J. Alzheimer disease, attention, and the cholinergic system. Alzheimer Disease and Associated Disorders. 9:1995;43-49
16. Leonard A.S., Hell J.W. Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. Journal of Biological Chemistry. 272:1997;12107-12115
17. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431
18. * nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. Journal of Neurochemistry. 80:2002;1071-1078
19. Pittaluga A., Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. European Journal of Pharmacology. 191:1990;231-234
20. 2+ block without depolarization. British Journal of Pharmacology. 130:2000;557-566
21. Pittaluga A., Pattarini R., Feligioni M., Raiteri M. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition. Journal of Neurochemistry. 76:2001;139-148
22. Raiteri L., Raiteri M. Synaptosomes still viable after 25 years of superfusion. Neurochemical Research. 25:2000;1265-1274
23. Raiteri M., Garrone B., Pittaluga A. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. Journal of Pharmacology and Experimental Therapeutics. 260:1992;238-242
24. Risso F., Parodi M., Grilli M., Molfino F., Raiteri M., Marchi M. Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release. Neurochemistry International. 44:2004;293-301
25. Salter M.W. D1 and NMDA receptors hook up: expanding on an emerging theme. Trends in Neurosciences. 26:2003;235-237
26. Sanchez Prieto J., Sihra T.S., Evans D., Ashton A., Dolly J.O., Nicholls D.G. Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes. European Journal of Biochemistry. 165:1987;675-681
27. Stigliani S., Raiteri L., Fassio A., Bonanno G. The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool. Journal of Neurochemistry. 85:2003;409-421
28. Terry A.V. Jr., Buccafusco J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. Journal of Pharmacology and Experimental Therapeutics. 306:2003;821-827
29. Verhage M., McMahon H.T., Ghijsen W.E.J.M., Boomsma F., Scholten G., Wiegant V.M., Nicholls D.G. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals. Neuron. 6:1991;517-524
30. Vizi E.S. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochemistry International. 33:1998;359-366
31. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends in Neurosciences. 20:1997;92-98